A Journey Through Time: Trace Pfizer's Evolution From 1849 To 2015
This article was originally published in Scrip
Pfizer Inc. this week has signed its biggest deal to date, agreeing to pay $160bn for Allergan Inc., to unshackle itself from a US corporate tax regime and create a pharmaceutical business that will dominate the industry.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.